Letko, Brosseau & Associates Inc Abb Vie Inc. Transaction History

Letko, Brosseau & Associates Inc

  • $5.37 Billion
  • Q3 2024

A detailed history of Letko, Brosseau & Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 316,834 shares of ABBV stock, worth $55.6 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
316,834
Previous 318,834 0.63%
Holding current value
$55.6 Million
Previous $54.7 Million 14.41%
% of portfolio
1.17%
Previous 1.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$163.84 - $199.33 $327,680 - $398,660
-2,000 Reduced 0.63%
316,834 $62.6 Million
Q2 2024

Aug 06, 2024
SELL
$154.79 - $180.76 $1.22 Million - $1.43 Million
-7,895 Reduced 2.42%
318,834 $54.7 Million
Q1 2024

May 08, 2024
SELL
$159.82 - $182.1 $1.42 Million - $1.62 Million
-8,905 Reduced 2.65%
326,729 $59.5 Million
Q4 2023

Feb 12, 2024
SELL
$137.6 - $154.97 $703,136 - $791,896
-5,110 Reduced 1.5%
335,634 $52 Million
Q3 2023

Nov 09, 2023
SELL
$133.59 - $154.65 $339,318 - $392,811
-2,540 Reduced 0.74%
340,744 $50.8 Million
Q2 2023

Aug 10, 2023
SELL
$132.51 - $164.9 $93,419 - $116,254
-705 Reduced 0.2%
343,284 $46.3 Million
Q1 2023

May 11, 2023
SELL
$144.61 - $166.54 $22.9 Million - $26.4 Million
-158,283 Reduced 31.51%
343,989 $54.8 Million
Q4 2022

Feb 10, 2023
SELL
$138.31 - $165.87 $7.63 Million - $9.15 Million
-55,155 Reduced 9.89%
502,272 $81.2 Million
Q3 2022

Nov 10, 2022
SELL
$134.21 - $153.93 $5.51 Million - $6.32 Million
-41,027 Reduced 6.86%
557,427 $74.8 Million
Q2 2022

Aug 09, 2022
SELL
$137.62 - $174.96 $8.32 Million - $10.6 Million
-60,440 Reduced 9.17%
598,454 $91.7 Million
Q1 2022

May 11, 2022
SELL
$131.98 - $163.75 $5.51 Million - $6.84 Million
-41,775 Reduced 5.96%
658,894 $107 Million
Q4 2021

Feb 09, 2022
SELL
$107.43 - $135.93 $2.41 Million - $3.05 Million
-22,455 Reduced 3.11%
700,669 $94.9 Million
Q3 2021

Nov 03, 2021
SELL
$106.4 - $120.78 $4.31 Million - $4.9 Million
-40,545 Reduced 5.31%
723,124 $78 Million
Q2 2021

Jul 29, 2021
SELL
$105.21 - $117.21 $992,656 - $1.11 Million
-9,435 Reduced 1.22%
763,669 $86 Million
Q1 2021

May 11, 2021
BUY
$102.3 - $112.62 $24.5 Million - $26.9 Million
239,117 Added 44.78%
773,104 $83.7 Million
Q4 2020

Feb 05, 2021
SELL
$80.49 - $108.67 $3.43 Million - $4.63 Million
-42,640 Reduced 7.39%
533,987 $57.2 Million
Q3 2020

Nov 09, 2020
SELL
$85.91 - $100.83 $4.82 Million - $5.66 Million
-56,125 Reduced 8.87%
576,627 $50.5 Million
Q2 2020

Aug 07, 2020
SELL
$73.37 - $98.18 $2.87 Million - $3.83 Million
-39,050 Reduced 5.81%
632,752 $62.1 Million
Q1 2020

May 14, 2020
BUY
$64.5 - $97.79 $758,197 - $1.15 Million
11,755 Added 1.78%
671,802 $51.2 Million
Q4 2019

Feb 07, 2020
SELL
$72.13 - $90.25 $1.75 Million - $2.19 Million
-24,295 Reduced 3.55%
660,047 $58.4 Million
Q3 2019

Nov 05, 2019
SELL
$62.98 - $75.72 $758,279 - $911,668
-12,040 Reduced 1.73%
684,342 $51.8 Million
Q2 2019

Aug 01, 2019
SELL
$65.7 - $83.98 $1.83 Million - $2.34 Million
-27,910 Reduced 3.85%
696,382 $50.6 Million
Q1 2019

May 10, 2019
BUY
$77.14 - $90.79 $12.8 Million - $15.1 Million
166,249 Added 29.79%
724,292 $58.4 Million
Q4 2018

Feb 08, 2019
SELL
$77.85 - $96.01 $512,953 - $632,609
-6,589 Reduced 1.17%
558,043 $51.4 Million
Q3 2018

Nov 08, 2018
SELL
$88.91 - $98.84 $1.51 Million - $1.68 Million
-17,010 Reduced 2.92%
564,632 $53.4 Million
Q2 2018

Aug 07, 2018
SELL
$89.78 - $106.23 $578,632 - $684,652
-6,445 Reduced 1.1%
581,642 $53.9 Million
Q1 2018

May 08, 2018
SELL
$92.01 - $123.21 $3.36 Million - $4.5 Million
-36,485 Reduced 5.84%
588,087 $55.7 Million
Q4 2017

Feb 20, 2018
SELL
$89.56 - $98.21 $1.34 Million - $1.47 Million
-14,975 Reduced 2.34%
624,572 $60.4 Million
Q3 2017

Nov 13, 2017
BUY
$69.85 - $89.22 $44.7 Million - $57.1 Million
639,547
639,547 $56.8 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email